BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 63 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,380,248 | -35.1% | 4,448,000 | -32.2% | 0.06% | -22.7% |
| Q1 2023 | $6,747,850 | +157.5% | 6,561,000 | +166.4% | 0.08% | +167.9% |
| Q4 2022 | $2,620,139 | +55.2% | 2,463,000 | +44.9% | 0.03% | +47.4% |
| Q3 2022 | $1,688,000 | +0.1% | 1,700,000 | 0.0% | 0.02% | -5.0% |
| Q2 2022 | $1,687,000 | -51.9% | 1,700,000 | -51.4% | 0.02% | -45.9% |
| Q1 2022 | $3,507,000 | -18.4% | 3,500,000 | -14.7% | 0.04% | -21.3% |
| Q4 2021 | $4,300,000 | -0.1% | 4,103,000 | -2.3% | 0.05% | -21.7% |
| Q3 2021 | $4,305,000 | -51.2% | 4,198,000 | -50.6% | 0.06% | -49.6% |
| Q2 2021 | $8,829,000 | +1690.9% | 8,500,000 | +1708.5% | 0.12% | +750.0% |
| Q1 2020 | $493,000 | -86.7% | 470,000 | -86.6% | 0.01% | -80.0% |
| Q4 2019 | $3,706,000 | +72.1% | 3,500,000 | +66.7% | 0.07% | +70.7% |
| Q1 2019 | $2,154,000 | -85.4% | 2,100,000 | -85.8% | 0.04% | -69.4% |
| Q4 2018 | $14,754,000 | -26.8% | 14,800,000 | -21.5% | 0.13% | -50.6% |
| Q3 2018 | $20,150,000 | -34.8% | 18,865,000 | -38.1% | 0.27% | -37.3% |
| Q2 2018 | $30,887,000 | +512.6% | 30,500,000 | +515.8% | 0.43% | +476.0% |
| Q3 2017 | $5,042,000 | – | 4,953,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 19,413,000 | $19,245,611 | 1.50% |
| SSI INVESTMENT MANAGEMENT LLC | 9,386,000 | $9,219,566 | 0.65% |
| PFM Health Sciences, LP | 15,000,000 | $14,771,520 | 0.57% |
| RWC Asset Management LLP | 11,000,000 | $10,848,475 | 0.52% |
| Sonora Investment Management Group, LLC | 6,280,000 | $6,184,858 | 0.52% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,020,000 | $23,654,128 | 0.46% |
| Lombard Odier Asset Management (Europe) Ltd | 7,224,000 | $7,124,489 | 0.34% |
| MACKAY SHIELDS LLC | 10,123,000 | $9,943,520 | 0.28% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,478,000 | $9,323,983 | 0.25% |
| Nicholas Investment Partners, LP | 2,940,000 | $2,887,868 | 0.20% |